कुल 25 हाल के अंदरूनी लेनदेन दर्ज हैं NeuroSense Therapeutics Ltd. (NRSN), जिसमें शामिल हैं 3 खरीद और 0 बिक्री.
हाल की गतिविधि वाले उल्लेखनीय अंदरूनी लोगों में शामिल हैं Binder Hagit, Russek-blum Niva, Eisenberg Or. अंदरूनी लेनदेन से पता चल सकता है कि कंपनी का नेतृत्व स्टॉक के मूल्यांकन और भविष्य की संभावनाओं को कैसे देखता है.
इनसाइडर ट्रेडिंग — NRSN
| तिथि |
नाम |
भूमिका |
लेनदेन प्रकार |
शेयर |
औसत मूल्य |
मूल्य |
स्वामित्व वाले शेयर |
| 2026-03-26 |
Binder Hagit |
General Manager |
RSU पुरस्कार |
200,000 |
- |
- |
521,806 |
| 2026-03-26 |
Russek-blum Niva |
Chief Technology Officer |
RSU पुरस्कार |
200,000 |
- |
- |
467,953 |
| 2026-03-26 |
Eisenberg Or |
Chief Financial Officer |
RSU पुरस्कार |
200,000 |
- |
- |
1,254,050 |
| 2026-03-18 |
Pellizzari Christine A |
Director |
अज्ञात |
- |
- |
- |
48,000 |
| 2026-03-18 |
Leuchtenberger Mark |
Director |
अज्ञात |
- |
- |
- |
75,000 |
| 2026-03-18 |
Claiborne Cary J |
Director |
अज्ञात |
- |
- |
- |
48,000 |
| 2026-03-18 |
Golan Roy |
Director |
अज्ञात |
- |
- |
- |
24,000 |
| 2026-03-18 |
Binder Hagit |
General Manager |
अज्ञात |
- |
- |
- |
10,000 |
| 2026-03-18 |
Tracik Ferenc |
Chief Medical Officer |
अज्ञात |
- |
- |
- |
189,618 |
| 2026-03-18 |
Ben-noon Alon |
10 Percent Owner, Officer: Chief Executive Officer |
अज्ञात |
- |
- |
- |
360,777 |
| 2026-03-18 |
Russek-blum Niva |
Chief Technology Officer |
अज्ञात |
- |
- |
- |
10,000 |
| 2026-03-18 |
Mandil-levin Revital |
Director |
अज्ञात |
- |
- |
- |
52,526 |
| 2026-03-18 |
Eisenberg Or |
Chief Financial Officer |
अज्ञात |
- |
- |
- |
139,416 |
| 2024-12-05 |
Ben-noon Alon |
10 Percent Owner, Officer: Chief Executive Officer |
अज्ञात |
80,000 |
$1.25 |
$100K |
- |
| 2024-08-15 |
Tracik Ferenc |
Chief Medical Officer |
अज्ञात |
66,667 |
$0.75 |
$50K |
- |
| 2024-08-15 |
Ben-noon Alon |
10 Percent Owner, Officer: Chief Executive Officer |
अज्ञात |
26,666 |
$0.75 |
$20K |
- |
| 2024-08-15 |
Eisenberg Or |
Chief Financial Officer |
अज्ञात |
66,666 |
$0.75 |
$50K |
- |
| 2023-03-10 |
Pellizzari Christine A |
Director |
अज्ञात |
72,000 |
$1.43 |
$102.96K |
- |
| 2023-03-10 |
Claiborne Cary J |
Director |
अज्ञात |
72,000 |
$1.43 |
$102.96K |
- |
| 2023-03-10 |
Mandil-levin Revital |
Director |
अज्ञात |
72,000 |
$1.43 |
$102.96K |
- |
| 2022-11-17 |
Binder Hagit |
General Manager |
अज्ञात |
36,000 |
$1.99 |
$71.64K |
- |
| 2022-04-25 |
Russek-blum Niva |
Chief Technology Officer |
अज्ञात |
36,000 |
$2.18 |
$78.48K |
- |
| 2022-03-13 |
Tracik Ferenc |
Chief Medical Officer |
अज्ञात |
108,000 |
$3.51 |
$379.08K |
- |
| 2022-01-01 |
Leuchtenberger Mark |
Director |
अज्ञात |
192,000 |
$3.51 |
$673.92K |
- |
| 2021-07-01 |
Eisenberg Or |
Chief Financial Officer |
अज्ञात |
21,000 |
$0.03 |
$693.00 |
- |
■ जानकारीपूर्ण — खुले बाजार में खरीद/बिक्री (सर्वाधिक महत्वपूर्ण)
■ गैर-जानकारी खरीद — पुरस्कार, विकल्प अभ्यास, रूपांतरण
■ गैर-जानकारी बिक्री — कर रोक, पुरस्कार बिक्री
■ तटस्थ — उपहार, ट्रस्ट, समाप्ति